No Result

View All Result

No products in the cart.

Home StudyGraphics

Phase II O-12-M1: Melflufen plus dexamethasone showed benefits in long-term survival outcomes in relapsed/refractory multiple myeloma

byKathleen Lau

February 5, 2021

in StudyGraphics

RELATED REPORTS

Intraarterial dexamethasone may be effective for pain relief following uterine fibroid embolization

Younger age and systemic metastases may independently predict survival among patients with choroidal metastases

2 Minute Medicine Rewind August 3rd, 2026

Tocilizumab is superior to rituximab for treatment of rheumatoid arthritis in patients with low or absent B-cell lineage expression

RelatedReports

Elagolix with add-back hormone therapy effective in reducing fibroid-associated menstrual bleeding

Chronic Disease

Intraarterial dexamethasone may be effective for pain relief following uterine fibroid embolization

August 5, 2026

Adalimumab aids in control of noninfectious uveitis

Chronic Disease

Younger age and systemic metastases may independently predict survival among patients with choroidal metastases

August 3, 2026

Weekly Rewinds

2 Minute Medicine Rewind August 3rd, 2026

August 3, 2026

Variability in interpretation of breast biopsy slides associated with low verification of atypia and ductal carcinoma in situ

Chronic Disease

A digital mental health intervention may improve anxiety in breast cancer survivors

July 31, 2026

Survival greater in cervical cancer patients undergoing abdominal hysterectomy compared to minimally invasive techniques: the LACC trial

2 Minute Medicine Rewind February 8, 2021

Quick Take: Association of Cereal, Gluten, and Dietary Fiber Intake With Islet Autoimmunity and Type 1 Diabetes

Higher consumption of refined grains other than white rice associated with a greater mortality and cardiovascular disease risk

Type I diabetes not associated with early menopause [OVADIA study]

Māori and Pacific New Zealanders may be disproportionately affected by type 2 diabetes-related clinical outcomes

2 Minute Medicine® is an award winning, physician-run, expert medical media company. Our content is curated, written and edited by practicing health professionals who have clinical and scientific expertise in their field of reporting. Our editorial management team is comprised of highly-trained MD physicians. Join numerous brands, companies, and hospitals who trust our licensed content.

Recent Reports

No Result

View All Result